A Study to Measure SARS-CoV-2 RNA in Human Saliva


About this study

The purpose of this study is to collect saliva specimens from individuals who tested positive for SARS-CoV-2 RNA in respiratory tract specimens to validate this specimen type for the SARS-Co-V-2 RNA Detection and Quantification digital droplet PCR-based assay, and to evaluate the use of SARS-CoV-2 viral load measured in saliva for correlation with levels in other specimen types, disease course, and/or response to therapy.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults, ≥ 18 years if age.
  • Subjects who have respiratory tract specimens positive for the SARS-CoV-2 virus.

Exclusion Criteria:

  • Individuals < 18 years of age.
  • Unable to provide consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ann Moyer, M.D., Ph.D.

Open for enrollment

Contact information:

Katelyn Reed B.S., M.H.S.

(507) 284-0503


More information


Publications are currently not available